These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8866638)

  • 1. Estimation of steady state antibiotic concentration in cerebrospinal fluid from single-dose kinetics.
    Nau R; Prange HW
    Eur J Clin Pharmacol; 1996; 49(5):407-9. PubMed ID: 8866638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections.
    Nau R; Sörgel F; Prange HW
    Clin Pharmacokinet; 1998 Sep; 35(3):223-46. PubMed ID: 9784935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of antibacterial agents in infections of the central nervous system.
    Thea D; Barza M
    Infect Dis Clin North Am; 1989 Sep; 3(3):553-70. PubMed ID: 2671139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma and cerebrospinal fluid concentrations of linezolid in neurosurgical critically ill patients with proven or suspected central nervous system infections.
    Luque S; Grau S; Alvarez-Lerma F; Ferrández O; Campillo N; Horcajada JP; Basas M; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2014 Nov; 44(5):409-15. PubMed ID: 25216547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic pharmacodynamics in cerebrospinal fluid.
    Lutsar I; McCracken GH; Friedland IR
    Clin Infect Dis; 1998 Nov; 27(5):1117-27, quiz 1128-9. PubMed ID: 9827256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Influencing Norvancomycin Concentration in Plasma and Cerebrospinal Fluid in Patients After Craniotomy and Dosing Guideline: A Population Approach.
    Li X; Wu Y; Sun S; Wang Q; Zhao Z
    Clin Ther; 2018 Jan; 40(1):74-82.e1. PubMed ID: 29229228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low flucloxacillin concentrations in a patient with central nervous system infection: the need for plasma and cerebrospinal fluid drug monitoring in the ICU.
    Abdul-Aziz MH; McDonald C; McWhinney B; Ungerer JP; Lipman J; Roberts JA
    Ann Pharmacother; 2014 Oct; 48(10):1380-4. PubMed ID: 24951308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experience in the use of the new antibiotics in suppurative diseases of the central nervous system].
    Samotokin BA; Podkolzin IuN
    Voen Med Zh; 1968 Jan; 1():29-33. PubMed ID: 5702127
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antibiotic diffusion to central nervous system].
    Cabrera-Maqueda JM; Fuentes Rumí L; Valero López G; Baidez Guerrero AE; García Molina E; Díaz Pérez J; García-Vázquez E
    Rev Esp Quimioter; 2018 Feb; 31(1):1-12. PubMed ID: 29390599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between vancomycin penetration into cerebrospinal fluid and protein concentration in cerebrospinal fluid/serum albumin ratio.
    Ishikawa M; Yamazaki S; Suzuki T; Uchida M; Iwadate Y; Ishii I
    J Infect Chemother; 2019 Feb; 25(2):124-128. PubMed ID: 30424949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentrations of fosfomycin in the cerebrospinal fluid of neurointensive care patients with ventriculostomy-associated ventriculitis.
    Pfausler B; Spiss H; Dittrich P; Zeitlinger M; Schmutzhard E; Joukhadar C
    J Antimicrob Chemother; 2004 May; 53(5):848-52. PubMed ID: 15056646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zidovudine concentration in brain extracellular fluid measured by microdialysis: steady-state and transient results in rhesus monkey.
    Fox E; Bungay PM; Bacher J; McCully CL; Dedrick RL; Balis FM
    J Pharmacol Exp Ther; 2002 Jun; 301(3):1003-11. PubMed ID: 12023531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Permeability of antibacterial drugs in the cerebrospinal fluid].
    Meyer FP; Walther H
    Z Arztl Fortbild (Jena); 1984; 78(17):703-10. PubMed ID: 6506776
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetic aspects of the treatment of infections in the central nervous system.
    Norrby R
    J Antimicrob Chemother; 1979 Nov; 5(6):630-3. PubMed ID: 536352
    [No Abstract]   [Full Text] [Related]  

  • 15. Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis.
    Cottagnoud P; Pfister M; Acosta F; Cottagnoud M; Flatz L; Kühn F; Müller HP; Stucki A
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3928-33. PubMed ID: 15388454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parameters important in short antibiotic courses.
    Pechère JC
    J Int Med Res; 2000; 28 Suppl 1():3A-12A. PubMed ID: 11092225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic aspects of cerebrospinal fluid penetration of fosfomycin.
    Pfeifer G; Frenkel C; Entzian W
    Int J Clin Pharmacol Res; 1985; 5(3):171-4. PubMed ID: 4018950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of cerebrospinal fluid inhibitory titers of antibiotics, based on pharmacokinetic/pharmacodynamic parameters, in the treatment of bacterial meningitis.
    Morikawa Y; Kitazato M; Morita T; Mizunaga S; Mitsuyama J
    J Infect Chemother; 2009 Aug; 15(4):233-8. PubMed ID: 19688242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal antibiotic dosing. The pharmacokinetic-pharmacodynamic interface.
    Reed MD
    Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):17-24. PubMed ID: 19667545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linezolid in the central nervous system: comparison between cerebrospinal fluid and plasma pharmacokinetics.
    Viaggi B; Paolo AD; Danesi R; Polillo M; Ciofi L; Del Tacca M; Malacarne P
    Scand J Infect Dis; 2011 Sep; 43(9):721-7. PubMed ID: 21585240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.